Rare Disease Family Registry Market (Cloud-Based): Growth Opportunities Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Cloud-Based Rare Disease Family Registry Market Grow Between 2026 And 2030?
The cloud-based rare disease family registry market has seen significant expansion in recent years. This market is expected to increase from $1.4 billion in 2025 to $1.65 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.7%. The observed growth in the past can be attributed to several factors, including the rise in rare disease research initiatives, greater involvement from patient advocacy, the expansion of clinical trial networks, the growing adoption of electronic data capture tools, and the necessity for centralized patient data systems.
The cloud-based rare disease family registry market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.15 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.5%. This projected growth during the forecast period is fueled by factors such as enhanced investments in developing orphan drugs, a greater need for generating real-world evidence, the expansion of research in precision medicine, the escalating application of AI-powered data analytics, and a heightened focus on research models centered around patients. Key trends for the forecast period encompass a wider embrace of cloud-based patient registries, an increased utilization of digital platforms for rare disease investigations, the evolving integration of genomic and clinical information, the broadening of global tools for clinical trial recruitment, and a strengthened emphasis on secure data exchange.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Primary Drivers Are Impacting The Cloud-Based Rare Disease Family Registry Market Growth?
A growing emphasis on precision medicine is anticipated to drive the expansion of the cloud-based rare disease family registry market in the future. Precision medicine is a medical strategy that customizes treatment and prevention approaches to an individual’s genetic, environmental, and lifestyle factors. Its adoption is increasing due to advancements in genomic sequencing, which enable medical professionals to understand patients’ genetic makeup more precisely. Cloud-based rare disease family registries aid precision medicine by gathering and centralizing comprehensive patient data, including genetic, clinical, and treatment information. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that in 2023, the Food and Drug Administration (FDA), a US-based federal agency, approved 16 new personalized therapies for patients with rare diseases, a significant increase from the six approvals in 2022; of these newly authorized treatments, seven target cancer, while three focus on other diseases and conditions. Therefore, the heightened focus on precision medicine is a key driver for the growth of the cloud-based rare disease family registry market.
How Is The Cloud-Based Rare Disease Family Registry Market Segmented Across Different Segment Categories?
The cloud-based rare disease family registry market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment Mode: Public Cloud, Private Cloud, Hybrid Cloud
3) By Application: Patient Data Management, Research, Clinical Trials, Genetic Data Collection, Other Applications
4) By End-User: Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Patient Advocacy Groups, Other End-Users
Subsegments:
1) By Software: Electronic Data Capture, Data Management Platform, Analytics And Reporting Tools, Patient Engagement Tools, Clinical Trial Management System
2) By Services: Implementation And Integration, Training And Support, Data Hosting And Security, Consulting Services, Maintenance And Upgrades
Which Trends Are Shaping Growth In The Cloud-Based Rare Disease Family Registry Market?
Leading companies in the cloud-based rare disease family registry market are implementing technological advancements, such as bilingual federated registries, to furnish patients, families, and researchers with secure, multi-location data platforms that enhance engagement and facilitate real-time data collection and analysis. A bilingual federated registry functions as a cloud-based system, allowing data to remain at local sites while accommodating multiple languages and adhering to regional consent and privacy regulations. For example, in June 2025, the National Organization for Rare Disorders (NORD), a U.S.-based nonprofit, outlined plans to launch two Canadian patient registries for PKU and MPS. Developed through collaboration with Canadian patient advocacy groups, researchers, and clinicians, these registries mark the first time the IAMRARE Program will be hosted outside the U.S. They are specifically designed to comply with provincial consent requirements, enable cooperative real-time data collection and analysis, and support initiatives to accelerate research, improve the understanding of rare metabolic disorders, and aid in the identification of participants for clinical trials.
Which Organizations Play A Role In The Cloud-Based Rare Disease Family Registry Market Landscape?
Major companies operating in the cloud-based rare disease family registry market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., ICON plc, Syneos Health Inc., Parexel International Corp., Medidata Solutions Inc., FIGMD Inc., OM1 Inc., Mission Health Labs Inc., TREAT-NMD Global Registries Platform, Seqster PDM Inc., ArborMetrix Inc., OpenClinica LLC, Pulse Infoframe Inc., Oracle Healthcare Pvt. Ltd., QuesGen Systems Inc., FTD Disorders Registry, Castor LLC, Data Registry Services LLC, Fibrolamellar Registry, Rare Central
Get The Full Cloud-Based Rare Disease Family Registry Market Report:
Which Region Is The Leading Market For The Cloud-Based Rare Disease Family Registry Market?
North America was the largest region in the cloud-based rare disease family registry market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud-based rare disease family registry market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cloud-Based Rare Disease Family Registry Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cloud-Based Rare Disease Family Registry Market 2026, By The Business Research Company
Rare Diseases Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/rare-diseases-treatment-global-market-report
Patient Registry Software Market Report 2026
https://www.thebusinessresearchcompany.com/report/patient-registry-software-global-market-report
Disease Management Apps Market Report 2026
https://www.thebusinessresearchcompany.com/report/disease-management-apps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
